Investigation of the Relationship between Topology and Selectivity for Druglike Molecules
- 13 October 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (21) , 7709-7714
Abstract
There is a strong interest in drug discovery and development to advance the understanding of pharmacological promiscuity. Improved understanding of how a molecular structure is related to promiscuity could help to reduce the attrition of compounds in the drug discovery process. For this purpose, a descriptor is introduced that describes the structural complexity of a compound based on the size of its molecular framework (MF) in relation to its overall size. It is defined as the fraction of the size of the molecular framework versus the size of the whole molecule (fMF). It is demonstrated that promiscuity correlates with fMF for large fMF values. The observed correlation is not due to lipophilicity. To provide further explanation of this observation, it was found that the number of terminal ring systems in a compound is correlated with promiscuity. The analysis presented here might help medicinal chemists to improve the selectivity for compounds in drug discovery projects.Keywords
This publication has 19 references indexed in Scilit:
- Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche CompoundsChemMedChem, 2009
- Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuityBioorganic & Medicinal Chemistry Letters, 2008
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Can we rationally design promiscuous drugs?Current Opinion in Structural Biology, 2006
- G-Protein-Coupled Receptor Affinity Prediction Based on the Use of a Profiling Dataset: QSAR Design, Synthesis, and Experimental ValidationJournal of Medicinal Chemistry, 2005
- The “promiscuous drug concept” with applications to Alzheimer's diseaseFEBS Letters, 2005
- Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophreniaNature Reviews Drug Discovery, 2004
- STI571 (Gleevec™) as a paradigm for cancer therapyTrends in Molecular Medicine, 2002
- The Properties of Known Drugs. 1. Molecular FrameworksJournal of Medicinal Chemistry, 1996
- Individual Comparisons by Ranking MethodsBiometrics Bulletin, 1945